Summary

In the 1980s, antimicrobial resistance among gram-negative (Gm) pathogens seemed to be under control. Much has since changed, and physicians are now facing unprecedented clinical challenges due to the growing proliferation of multidrug-resistant Gm pathogens. This article describes current epidemiological, mechanistic, and demographic trends that are related to this worldwide epidemic.